Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 08, 2019 ) Market Definition
Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications.
Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050.
The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices.
Request Sample with Future Advancement @ https://www.theinsightpartners.com/sample/TIPHE100000819/
For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
In addition, in July 2018, Abbott announced to have a FDA approval for the FreeStyle Libre 14 day Flash Glucose Monitoring system that allows people with diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer increasing demand for the products, hence providing better share to the market players.
Leading Industry Players
The major players operating in the market of Insulin Delivery Devices market include Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited, Biotronik SE & Co. Kg, Stentys SA, B. Braun Melsungen AG, Translumina GmbH, and Terumo Corporation.
The market for Insulin Delivery Devices has been witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The Insulin Delivery Devices market is subject to strict and mandated regulatory policies. The companies operating in the market follow stringent regulations of the manufacturing guidelines.
In addition, these manufacturing companies are focusing to invest in R&D to develop advanced products for end users such as, hospitals, ambulatory surgical centers, and the cardiac centers, among others.
Detailed Segmentation
Product Insights
The global insulin delivery devices market by product was led by insulin pens segment. In 2017, the insulin pens segment held a largest market share of 31.3% of the insulin delivery devices market, by product. The segment is also expected to dominate the market in 2025, since they offer increasing ease of use; increasing patient satisfaction and adherence; accuracy for delivering small doses of insulin.
End User Insights
The insulin delivery devices market by end user was segmented into patients/homecare and hospitals & clinics. The patients/homecare segment held the largest share of the market, by end user. The segment is also likely to dominate during the forecast period, as it allows a patient to regulate as well as monitor the glucose levels as well as administer insulin at home.
Strategic Insights
Product approvals and agreements were observed as the most adopted strategy in global insulin delivery devices industry. Few of the product approvals and agreements made by the players in the market are listed below;
2018: In June, 2018, Medtronic received CE Mark for its MiniMed(TM) 670G Hybrid Closed Loop System.
2018: In February, 2018, Tandem and Rubin Medical signed an agreement for distribution of insulin pumps in Scandinavia.
Purchase Premium Report @ https://www.theinsightpartners.com/buy/TIPHE100000819/
Regional Framework
North America
S. Canada Mexico Europe France Germany UK Asia Pacific (APAC)
China India Japan Middle East & Africa (MEA)
Saudi Arabia South Africa UAE South America (SAM) - Brazil
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
533, 5th Floor, Amanora Chambers,
Amanora Township, East Block,
Kharadi Road, Hadapsar, Pune-411028
Email: sales@theinsightpartners.com
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|